Ticker Details
Larimar Therapeutics, Inc. Common Stock
IPO Date:	July 1, 2014
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$246.78M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.28 | 3.83%
Avg Daily Range (30 D):	$0.10 | 3.13%
Avg Daily Range (90 D):	$0.12 | 3.39%

Institutional Daily Volume
Avg Daily Volume:	.24M
Avg Daily Volume (30 D):	2.89M
Avg Daily Volume (90 D):	1.88M

Trade Size
Avg Trade Size (Sh.):	136
Avg Trade Size (Sh.) (30 D):	169
Avg Trade Size (Sh.) (90 D):	154

Institutional Trades
Total Institutional Trades:	220
Avg Institutional Trade:	$1.53M
Avg Institutional Trade (30 D):	$.85M
Avg Institutional Trade (90 D):	$.85M
Avg Institutional Trade Volume:	.24M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.67M
Avg Closing Trade (30 D):	$.54M
Avg Closing Trade (90 D):	$.55M
Avg Closing Volume:	280.51K

News

Oct 16, 2025 @ 8:44 AM Larimar Therapeutics, Inc. Investigated for Securi... Source: Prnewswire

Oct 16, 2025 @ 1:30 AM Larimar Therapeutics, Inc. Investigated for Securi... Source: Business Wire

Oct 16, 2025 @ 1:09 AM LRMR Investors Have Opportunity to Join Larimar Th... Source: Business Wire

Sep 29, 2025 @ 3:20 PM Larimar Therapeutics Stock Falls After Patients Re... Source: Vandana Singh

Sep 29, 2025 @ 11:00 AM Larimar Therapeutics Announces Positive Data from ... Source: Larimar Therapeutics

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.61	$-.41	$-.46
Diluted EPS	$-.61	$-.41	$-.46
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-47.71M	$-26.18M	$-29.28M
Operating Income / Loss	$-49.5M	$-27.79M	$-31.19M
Cost of Revenue
Net Cash Flow		$M	$M
PE Ratio